RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Stu...

Por Tripp, Catherine S., Cuff, Carolyn, Campbell, Andrew L., Hendrickson, Barbara A., Voss, Jeff, Melim, Terry, Wu, Chengbin, Cherniack, Andrew D., Kim, Kenneth
Publicado no Adv Ther (2017)